Clinical trial
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic…
NCT00005832 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00005832 |
|---|---|
| Title | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
| Official title | A Phase II Trial of R115777 (NSC #702818) in Patients With Advanced Pancreas Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | R115777 |
| Enrollment | 58 |
| Start date | Jun 1, 2000 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Apr 26, 2004 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: